Apyx Medical
APYX
56 hedge funds and large institutions have $94.4M invested in Apyx Medical in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 9 closing their positions.
5,653% more call options, than puts
Call options by funds: $1.09M | Put options by funds: $19K
62% more capital invested
Capital invested by funds: $58.2M → $94.4M (+$36.3M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 55 → 56 (+1)
3.8% less ownership
Funds ownership: 58.05% → 54.26% (-3.8%)
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$11.6M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.76M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.28M |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$910K |
| 5 |
RA
Royce & Associates
New York
|
+$738K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$8.21M |
| 2 |
CAC
Cowen and Company
New York
|
-$5.11M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$2.45M |
| 4 |
JP Morgan Chase
New York
|
-$1.41M |
| 5 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$1.36M |
APYX Hedge Fund Activity: Q2 2023 in Review
56 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2023, worth a combined $94.4M — up 62% from $58.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new APYX positions and 9 closed out — a net gain of 1 holder — while 16 added to existing stakes and 21 trimmed.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $11.6M. The largest seller was RTW Investments, cutting an estimated $8.21M.
- 56 institutional investors held Apyx Medical (APYX) as of Q2 2023, up from 55 in Q1 2023.
- Funds reported $94.4M of Apyx Medical stock for Q2 2023, up 62% quarter-over-quarter.
- 10 funds opened new Apyx Medical positions in Q2 2023 and 9 closed out, a net change of +1 holder.
- The largest Apyx Medical buyer in Q2 2023 was Divisadero Street Capital Management, an estimated $11.6M added.
- The largest Apyx Medical seller in Q2 2023 was RTW Investments, an estimated $8.21M sold.
Based on aggregated 13F filings for Q2 2023.